Records containing: Neoplasms
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2019-04-01A Phase I Dose Escalation Study of Oral MK-2206 in Patients With Locally Advanced or Metastatic Solid Tumors
-
CLINICAL_TRIALS study record update · 2019-03-29A PHASE 1 DOSE ESCALATION STUDY EVALUATING THE SAFETY AND TOLERABILITY OF PF-06650808 IN PATIENTS WITH ADVANCED SOLID TUMORS
-
CLINICAL_TRIALS study record update · 2019-03-28Single Arm Study of the Combination of Biweekly Avastin and Docetaxel as the First Line Treatment for Patients With Metastatic Breast Cancer
-
CLINICAL_TRIALS study record update · 2019-03-26Phase I Pharmacokinetic Study of Belinostat for Solid Tumors and Lymphomas in Patients With Varying Degrees of Hepatic Dysfunction
-
CLINICAL_TRIALS study record update · 2019-03-26A Phase III Study of Comparing the Maintenance Treatment of Apatinib, Capecitabine and Observation After First-line Therapy in Advanced Gastric Cancer
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2019-03-13Radiomics and Clinical Variables Can Differentiate Malignant Nodules and Detect Invasive Adenocarcinoma in Pulmonary Nodules: a Multi-center Study
-
CLINICAL_TRIALS study record update · 2019-03-05Phase II Study of Avelumab in Multiple Relapsed/Refractory Testicular Germ Cell Cancer.
-
CLINICAL_TRIALS study record update · 2019-02-21An Open Label Positron Emission Tomography (PET) Imaging Study Using 89Zirconium to Investigate the Biodistribution of Anti-HER3 Monoclonal Antibody (mAb) GSK2849330 and Characterize Its Dose-receptor Occupancy Relationship in Subjects With Advanced HER3-Positive Solid Tumors
-
CLINICAL_TRIALS study record update · 2019-02-21A Phase 1 Dose-finding and Pharmacokinetic Study of DpC, Administered Orally to Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2019-02-11Multi-arm, Non-randomized, Open-Label Phase IB Study to Evaluate GSK3052230 in Combination With Paclitaxel and Carboplatin, or Docetaxel or as Single Agent in Subjects With Solid Malignancies and Deregulated FGF Pathway Signaling
-
CLINICAL_TRIALS study record update · 2019-02-06Comparison of the Healing of Chemotherapy-Induced Oral Mucositis Using Oral Defense Toothpaste Versus Crest Toothpaste and Magic Mouth Rinse
-
CLINICAL_TRIALS study record update · 2019-02-05Understanding Patients and Prescriber Perceptions of Cell and Gene Therapy (CGT) in Oncology
-
CLINICAL_TRIALS study record update · 2019-02-01An Open Label Phase I Dose Escalation Trial of Intravenous BI 6727 in Combination With Oral BIBW 2992 in Patients With Advanced Solid Tumours With Repeated Administration in Patients With Clinical Benefit
-
CLINICAL_TRIALS study record update · 2019-01-31A Phase I Dose Escalation Trial of BI 6727 in Combination With Cisplatin or Carboplatin in Patients With Advanced or Metastatic Solid Tumors
-
CLINICAL_TRIALS study record update · 2019-01-31Investigation of the Metabolism, Excretion and Pharmacokinetics of an Openlabel Single Dose of 300 mg [14C]Volasertib Administered Intravenously in Patients With Various Solid Tumours With a Possible Extension Phase With Nonlabelled Drug
-
CLINICAL_TRIALS study record update · 2019-01-30To Evaluate the Safety & Palliative Treatment Effect on Patients With Solid Cancers by Immunostimulating Interstitial Laser Thermotherapy (imILT)
-
CLINICAL_TRIALS study record update · 2019-01-22Improvement of Information to Cancer Patients' Caregivers: a Randomised Intervention Study
-
CLINICAL_TRIALS study record update · 2019-01-18Phase 1 Study of Anti-TGFβRII Monoclonal Antibody IMC-TR1 (LY3022859) in Patients With Advanced Solid Tumors That Have Failed Standard Therapy or for Which No Standard is Available
-
CLINICAL_TRIALS study record update · 2019-01-04An Open Label Phase I Dose Finding Study of BI 860585 Administered Orally in a Continuous Dosing Schedule as Single Agent and in Combination With Exemestane or With Paclitaxel in Patients With Various Advanced and/or Metastatic Solid Tumours
-
CLINICAL_TRIALS study record update · 2019-01-03Phase I-II Study of Intratumoral Urelumab Combined With Nivolumab in Patients With Solid Tumors
-
CLINICAL_TRIALS study record update · 2018-12-21A PHASE 1, OPEN-LABEL, DOSE-ESCALATION STUDY TO EVALUATE SAFETY, PHARMACOKINETICS AND PHARMACODYNAMICS OF 2 DOSING SCHEDULES OF PF-00299804 IN PATIENTS WITH ADVANCED MALIGNANT SOLID TUMORS
-
CLINICAL_TRIALS study record update · 2018-12-21An Open Label Phase Ia/Ib Study of Two Dosing Schedules of BI 847325, Orally Administered Once a Day in Patients With Advanced Solid Tumours, With Repeated Cyclic Administration in Patients With Clinical Benefit
-
CLINICAL_TRIALS study record update · 2018-12-07Evaluation of the Organization of Continuity of Care for Home Hospice Patients by Four Parisian Health Networks
-
CLINICAL_TRIALS study record update · 2018-11-19Interindividual Genetic Variability as a Determinant of Chemotherapy Toxicity and Response in Pediatric Oncology/Bone Marrow Transplantation Patients
-
CLINICAL_TRIALS study record update · 2018-11-02A Phase 1 Study Of Pf-05212384 (Also Known As Pki-587) Administered As An Intravenous Infusion To Patients With Solid Tumors